article

Bioprocessing & Bioproduction In-Depth Focus 2019

The process of manufacturing a biotherapeutic drug entails numerous quality control measures to ensure safety and efficacy. The articles in this in-depth focus discuss higher order structure analysis and host cell protein contamination issues.











    To read this In-Depth Focus in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


    *

    *

    *

    *

    *

    *

    *

    *

    This content is provided to you for free thanks to the kind support of our sponsors: Merck

    • A contribution from scientists at Celldex Therapeutics describes how they ensure higher order structure (HOS) is maintained by monitoring it throughout the production process.
    • This article by Vanda Dolabela de Magalhães highlights a concern in biotechnological product manufacture; that of host cell protein contamination. You can hear the thoughts of six Brazilian companies that work in the field regarding how remaining low-level contamination should be tackled.

     

    Send this to a friend